Bio-orthogonally catalyzed lethality strategy generates targeting drugs from within tumors

COVID-19 has more people seeking help for addiction and mental health. But treatment centers struggle with outbreaks
25 January 2021
Missing protein helps small cell lung cancer evade immune defenses
25 January 2021

Bio-orthogonally catalyzed lethality strategy generates targeting drugs from within tumors

Cancer is the second leading cause of death in the world. The number of deaths and incidences is increasing each year. The metal-based anticancer drugs were used clinically worldwide, but suffer from poor selectivity, serious side effects and drug resistance. Tumor-targeting drug development is the basis for precise cancer treatment.

Comments are closed.